Stockholm-based biotech focused on industrial-scale production of GMP-certified mesenchymal stem cells (MSCs) for research and clinical use, aiming to lower costs and expand access to high-quality allogeneic MSCs.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €12 M | Oct, 2025 | unspecified |
Frequently Asked Questions
What industries does Cellcolabs operate in?
Cellcolabs operates in the following industries: biotechnology, life sciences, cell therapy, regenerative medicine.
When was Cellcolabs founded?
Cellcolabs was founded on 2025-10-28.
How much total funding has Cellcolabs raised?
Cellcolabs has raised a total of $12,000,000.
Who are the investors in Cellcolabs?
The investors in Cellcolabs are: Titian Life Sciences.